Temasek beefs up footprint in medtech sector
Accuron Technologies buys majority stake in device maker; ASLAN Pharmaceuticals gets set for 2017 IPO
Singapore
THE medical technology (medtech) sector in Singapore is primed for a shot in the arm.
On Monday, investment firm Temasek Holdings announced that its tech and engineering holding company Accuron Technologies has bought a majority stake in Malaysian medical device maker Aurum Healthcare Sdn Bhd, augmenting Temasek's medtech offerings and footprint.
ASLAN Pharmaceuticals, a Temasek-backed biotech startup, also anno…
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
'Harvesting data': Latin American AI startups transform farming
After long peace, Big Tech faces US antitrust reckoning
Tech’s cash crunch sees creditors turn ‘violent’ with one another
Tech millionaires chase billionaire tax shields with ‘swap fund’
Elon Musk’s Starlink profits are more elusive than investors think
Hollywood animation, VFX unions fight AI job cut threat